Long Read Sequencing Market Segmentation:
Trade Segment Analysis
In the trade segment, the merchant sub-segment controls the segment and is predicted to retain the share value of 64.7% by 2034. Merchant trade encompasses the sale of sequencing platforms, reagents, and services to third-party customers like clinical laboratories, CROs, and biotech companies, allowing broader market coverage. The segment is fueled by the outsourcing of genomic testing by hospitals and research centers to commercial service providers due to cost-effectiveness and scalability. As per the U.S. Census Bureau report, the exports of nucleic acid-based diagnostics, such as sequencing kits and instruments, reached $4.7 billion in 2023, which indicates a healthy global merchant supply chain. As the need for quick and decentralized genomic analysis increases, especially in oncology and infectious disease diagnostics, the merchant model will continue to dominate till 2034.
Technology Segment Analysis
Under the technology segment, nanopore sequencing technology leads the segment and is poised to hold the share value of 55.9% by 2034. Nanopore sequencing segment is driven by its real-time, portable, and cost-effective platform, benefiting resource-constrained and decentralized clinical environments. This technology is capable of handling ultra-long reads of less than 2 Mb and is increasingly applied in point-of-care diagnostics, such as tumor sequencing and infectious disease surveillance. As per the National Human Genome Research Institute report, the nanopore sequencing is poised to redefine real-time genome analysis practiced in hospitals and field diagnostics.
End user Segment Analysis
Hospitals and diagnostic labs dominate the end user segment and are anticipated to hold the market share of 41.6% by 2034. The segment is driven by rising clinical utilities for long read sequencing in cancer profiling, complex genetic disorders, and infectious disease management. Hospitals are actively integrating LRS platforms into precision medicine workflows, aided by private and public funding programs. The growing need for precise, real-time genomic insights is driving diagnostic labs to expand their capabilities, particularly those connected to national genomics programs. Moreover, the research and academic institutions continue to play a vital role in early-stage application development and innovation.
Our in-depth analysis of the global long-read sequencing market includes the following segments:
|
Segment |
Subsegments |
|
Technology |
|
|
Application |
|
|
End user |
|
|
Trade |
|
